AbbVie, Inc. (ABBV)

225.55 +1.20 (+0.53%) USD  |  NYSE  |  Feb 20, 13:57
More

AbbVie Consensus Recommendation

Consensus Recommendation Chart

View Consensus Recommendation for ABBV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Consensus Recommendation Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Consensus Recommendation Range, Past 5 Years

View Consensus Recommendation Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Consensus Recommendation Benchmarks

View Consensus Recommendation Benchmarks
Start Trial
Amgen, Inc. Upgrade
Biogen, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
Johnson & Johnson Upgrade
Eli Lilly & Co. Upgrade